- Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder
-
Kang H, Yoon BH, Bahk WM, Woo YS, Kim W, Lee J, Sohn I, Park SY, Jon DI, Jung MH, Kim MD, Jung YE, Sung HM, Park YM, Lee JG, Lee SY, Jang SH, Lim ES, Shim IH, Lee K, Jang SH
- KMID: 2539663
- Clin Psychopharmacol Neurosci.
- 2023 Feb;21(1):188-196.
- doi: 10.9758/cpn.2023.21.1.188
Objective: The Functioning Assessment Short Test (FAST) is a relatively specific test for bipolar disorders designed to assess the main functioning problems experienced by patients. This brief instrument includes 24... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
-
Jeong JH, Bahk WM, Woo YS, Yoon BH, Lee JG, Kim W, Sohn I, Park SY, Shim SH, Seo JS, Choo IH, Yang CM, Jung MH, Jon DI, Kim MD
- KMID: 2539648
- Clin Psychopharmacol Neurosci.
- 2023 Feb;21(1):32-48.
- doi: 10.9758/cpn.2023.21.1.32
The objective of this study was to compare recommendations of the Korean Medication Algorithm Project for Bipolar Disorder 2022 (KMAP-BP 2022) with other recently published guidelines for treating bipolar disorder.... -
- CITED
-
- Close
- SHARE
-
- Close
- Sex Differences in COVID-19 Infection Fear in a Community Sample of Korean Adults Using Quantile Regression
-
Na H, Jung YE, Park C, Lee C, Kim MD, Bahk WM
- KMID: 2539188
- J Korean Med Sci.
- 2023 Jan;38(4):e17.
- doi: 10.3346/jkms.2023.38.e17
This study aims to explore the impact of distributional changes in coronavirus disease 2019 (COVID-19) infection fear with sex differences. A quota sampling strategy was followed and 483 Korean adults... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary
-
Woo YS, Bahk WM, Jeong JH, Lee JG, Kim W, Sohn I, Park SY, Shim SH, Seo JS, Choo IH, Yang CM, Jung MH, Jon DI, Kim MD, Yoon BH
- KMID: 2536487
- Clin Psychopharmacol Neurosci.
- 2022 Nov;20(4):747-761.
- doi: 10.9758/cpn.2022.20.4.747
Objective: We revised the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP), first published in 2002 and revised in 2006, 2010, 2014, and 2018, to reflect recent progress in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Treatment Strategy According to Safety and Tolerability
-
Park SY, Bahk WM, Woo YS, Jeong JH, Yoon BH, Seo JS, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Kim MD, Sohn I
- KMID: 2536667
- J Korean Neuropsychiatr Assoc.
- 2022 Nov;61(4):274-280.
- doi: 10.4306/jknpa.2022.61.4.274
Objectives The safety and tolerability of drugs are very important to ensure compliance and efficacy in the treatment of bipolar disorders. An expert opinion survey was conducted on treatment strategies... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical Illnesses
-
Jung MH, Bahk WM, Woo YS, Jeong JH, Yoon BH, Seo JS, Yang CM, Kim W, Lee JG, Shim SH, Choo IH, Park SY, Sohn I, Jon DI, Kim MD
- KMID: 2536666
- J Korean Neuropsychiatr Assoc.
- 2022 Nov;61(4):267-273.
- doi: 10.4306/jknpa.2022.61.4.267
Objectives The present study was carried out to revise the guidelines for the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) 2018. The revision was carried out based on expert... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: The Elderly
-
Choo IH, Bahk WM, Woo YS, Jeong JH, Yoon BH, Seo JS, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD
- KMID: 2536665
- J Korean Neuropsychiatr Assoc.
- 2022 Nov;61(4):261-266.
- doi: 10.4306/jknpa.2022.61.4.261
Objectives The fifth revision of the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was undertaken to provide more precise guidelines for clinicians. In this study, we evaluated treatment strategies... -
- CITED
-
- Close
- SHARE
-
- Close
- Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
-
Woo YS, Park SY, Yoon BH, Choi WS, Wang SM, Bahk WM
- KMID: 2532823
- Clin Psychopharmacol Neurosci.
- 2022 Aug;20(3):567-572.
- doi: 10.9758/cpn.2022.20.3.567
Objective: The purpose of this study was to compare the efficacy and tolerability of continued olanzapine (OLA) versus amisulpride (AMI) augmentation in schizophrenic patients with poor response to OLA monotherapy. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Rapid Cycling
-
Jeong JH, Bahk WM, Woo YS, Yoon BH, Seo JS, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Park SY, Sohn I, Kim MD, Jung MH, Jon DI
- KMID: 2532713
- J Korean Neuropsychiatr Assoc.
- 2022 Aug;61(3):204-213.
- doi: 10.4306/jknpa.2022.61.3.204
Objectives This study revised the Korean Medication Algorithm Project for Bipolar Disorder 2018 for rapid cycling. Methods Questionnaires to survey the expert opinion of medication for rapid cycling were completed by... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Children and Adolescents
-
Yang CM, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Kim W, Lee JG, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH, Shim SH
- KMID: 2532704
- J Korean Neuropsychiatr Assoc.
- 2022 Aug;61(3):224-236.
- doi: 10.4306/jknpa.2022.61.3.224
Objectives The objective of this study was to revise the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) 2022: children and adolescents. Methods We performed a survey, using a questionnaire comprising... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Maintenance Therapy
-
Lee JG, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Yang CM, Kim W, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH
- KMID: 2532703
- J Korean Neuropsychiatr Assoc.
- 2022 Aug;61(3):214-223.
- doi: 10.4306/jknpa.2022.61.3.214
Objectives In this study, we investigated and organized the maintenance-treatment strategies for Bipolar I and II disorders outlined in The Korean Medication Algorithm Project for Bipolar disorder 2022 (KMAP-BP 2022). Methods... -
- CITED
-
- Close
- SHARE
-
- Close
- Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
-
Seo JC, Jon DI, Shim SH, Sung HM, Woo YS, Hong J, Park S, Seo JS, Bahk WM
- KMID: 2530476
- Clin Psychopharmacol Neurosci.
- 2022 May;20(2):402.
- doi: 10.9758/cpn.2022.20.2.402
-
- CITED
-
- Close
- SHARE
-
- Close
- Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
-
Lee JG, Woo YS, Park SW, Seog DH, Seo MK, Bahk WM
- KMID: 2530452
- Clin Psychopharmacol Neurosci.
- 2022 May;20(2):228-239.
- doi: 10.9758/cpn.2022.20.2.228
Bipolar disorder is a mental illness that causes extreme mood swings and has a chronic course. However, the mechanism by which mood episodes with completely opposite characteristics appear repeatedly, or... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Depressive Episode
-
Seo JS, Woo YS, Bahk WM, Jeong JH, Yoon BH, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD
- KMID: 2530031
- J Korean Neuropsychiatr Assoc.
- 2022 May;61(2):123-132.
- doi: 10.4306/jknpa.2022.61.2.123
Objectives After the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was developed in 2002, its fifth revision was completed in 2022 to reflect the recent rapid developments and research... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Manic Episode
-
Woo YS, Bahk WM, Jeong JH, Yoon BH, Seo JS, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD
- KMID: 2530028
- J Korean Neuropsychiatr Assoc.
- 2022 May;61(2):110-122.
- doi: 10.4306/jknpa.2022.61.2.110
Objectives The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) is a consensus-based medication guideline. To reflect advances in pharmacotherapy for bipolar disorders, we updated KMAP-BP to provide more timely... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Medication Algorithm Project for Bipolar Disorder 2022: Overview
-
Kim W, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Yang CM, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH
- KMID: 2530027
- J Korean Neuropsychiatr Assoc.
- 2022 May;61(2):98-109.
- doi: 10.4306/jknpa.2022.61.2.98
Objectives The pharmacotherapy of bipolar disorder is complex. A treatment guideline or algorithm can help clinicians implement better practices and clinical decisions. Therefore, the Korean Medication Algorithm Project for Bipolar... -
- CITED
-
- Close
- SHARE
-
- Close
- The Willingness of Enduring Drug Side Effects in the Patients of Depressive Disorders: From the Results of Korean Nationwide Patients’ Perspectives Survey Study
-
Ko M, Song HR, Kim SY, Jung YE, Kim W, Seo JS, Sohn I, Lee K, Lee JH, Chung SK, Lee SY, Hong JW, Yoon BH, Woo YS, Bahk WM
- KMID: 2529979
- J Korean Neuropsychiatr Assoc.
- 2022 May;61(2):74-79.
- doi: 10.4306/jknpa.2022.61.2.74
Objectives There has been increased use of medications in treating depressive disorders. Nowadays, patient value is an important part of prescribing medications. This study examines depressive patients’ perspectives on the side... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
-
Shim Sh, Woo YS, Kim JS, Heo IS, Yoon Hj, Sung HM, Lee J, Bahk WM
- KMID: 2526856
- Clin Psychopharmacol Neurosci.
- 2022 Feb;20(1):143-153.
- doi: 10.9758/cpn.2022.20.1.143
Objective: This study aimed to compare the efficacy and safety of atomoxetine (ATX) and OROS methylphenidate (MPH) as adjunctive to selective serotonin reuptake inhibitors (SSRIs) in adults with attention-deficit hyperactivity... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
-
Seo JC, Jon DI, Shim SH, Sung HM, Woo YS, Hong J, Park S, Seo JS, Bahk WM
- KMID: 2526854
- Clin Psychopharmacol Neurosci.
- 2022 Feb;20(1):126-134.
- doi: 10.9758/cpn.2022.20.1.126
Objective: This study investigated the prevalence and comorbidities of attention deficit hyperactivity disorder (ADHD) among adults and children/adolescents in Korea. Methods: This study used data from the Korea Health Insurance Review... -
- CITED
-
- Close
- SHARE
-
- Close
- The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
-
Woo YS, Bahk WM, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ
- KMID: 2526846
- Clin Psychopharmacol Neurosci.
- 2022 Feb;20(1):37-50.
- doi: 10.9758/cpn.2022.20.1.37
The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) first was published in 2002, and has been revised four times, in 2006, 2012, 2017, and 2021. In this review, we... -
- CITED
-
- Close
- SHARE
-
- Close
